These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 28561532)

  • 1. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
    Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
    Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of albumin in patients with head and neck cancer.
    Danan D; Shonka DC; Selman Y; Chow Z; Smolkin ME; Jameson MJ
    Laryngoscope; 2016 Jul; 126(7):1567-71. PubMed ID: 26864349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment Dysphagia Inventory and videofluorographic swallowing study as prognostic indicators of early survival outcomes in head and neck cancer.
    Yang CJ; Roh JL; Choi KH; Kim MJ; Choi SH; Nam SY; Kim SY
    Cancer; 2015 May; 121(10):1588-98. PubMed ID: 25639759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of posttreatment neutrophil-lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Kim DY; Kim IS; Park SG; Kim H; Choi YJ; Seol YM
    Auris Nasus Larynx; 2017 Apr; 44(2):199-204. PubMed ID: 27269133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
    Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Kim SA; Roh JL; Lee SA; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Cancer; 2016 Jan; 122(1):131-40. PubMed ID: 26371775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.
    Roslind A; Johansen JS; Christensen IJ; Kiss K; Balslev E; Nielsen DL; Bentzen J; Price PA; Andersen E
    Int J Cancer; 2008 Feb; 122(4):857-63. PubMed ID: 17957792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
    Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D; Vendrell JJ; León X; Vilaseca I; Terra X
    Head Neck; 2017 Dec; 39(12):2501-2511. PubMed ID: 28963801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
    Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
    Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 15. Noncancer-Related Health Events and Mortality in Head and Neck Cancer Patients After Definitive Radiotherapy: A Prospective Study.
    Kang HS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Medicine (Baltimore); 2016 May; 95(19):e3403. PubMed ID: 27175640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment High MCV as Adverse Prognostic Marker in Nonanemic Patients with Head and Neck Cancer.
    Borsetto D; Polesel J; Tirelli G; Menegaldo A; Baggio V; Gava A; Nankivell P; Pracy P; Fussey J; Boscolo-Rizzo P
    Laryngoscope; 2021 Mar; 131(3):E836-E845. PubMed ID: 32589769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
    Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
    Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
    Kuwahara T; Takahashi H; Sano D; Matsuoka M; Hyakusoku H; Hatano T; Hiiragi Y; Oridate N
    Anticancer Res; 2018 Sep; 38(9):5321-5330. PubMed ID: 30194184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy.
    Platek ME; Reid ME; Wilding GE; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Warren GW; Sullivan M; Thorstad WL; Khan MK; Loree TR; Singh AK
    Head Neck; 2011 Nov; 33(11):1561-8. PubMed ID: 21990220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.